ARCHIVES

Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer

This article is from The Cancer Letter archive.

Vol. 21 No. 18 | May 5, 1995

Download PDF Visit The Full Archive

Related Articles

Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable

April 26, 2013

NCI To Cut Smoking Intervention Study By 20%, Says Chemoprevention Accrual Has Priority

November 6, 1992

Cancer Letter On Vacation

August 3, 1984

St. Jude Offers Two Fellowships

July 18, 1986

NCI Gets Out of the News Business

January 25, 2013

CCIRC Loses Policy Making, Protocol Review

September 26, 1975